+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemostasis Diagnostics Market by Product Type, by Test Type, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, and D Dimer, and by End-User

  • ID: 4853893
  • Report
  • January 2019
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 3

The report covers a forecast and an analysis of the Hemostasis Diagnostics Market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints of the Hemostasis Diagnostics Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hemostasis Diagnostics Market on a global level.

In order to give the users of this report a comprehensive view of the Hemostasis Diagnostics Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved on the market on a global and regional basis.

The study provides a decisive view of the hemostasis diagnostics market by segmenting the market based on product type, test type, end-user, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024. 

By product type, the hemostasis diagnostics market is segmented into laboratory systems, consumables, and point-of-care testing systems. By test type, the hemostasis diagnostics market is segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, and D dimer. By end-user, the hemostasis diagnostics Market is segmented into hospital and clinics, independent diagnostic laboratories, and home care settings.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, such as the U.S., Germany, France, UK, China, Japan, India, and Brazil.

The major players of the global hemostasis diagnostics market include Siemens Healthineers, Abbott Laboratories, Instrumentation Laboratory, Thermo Fisher Scientific Inc., Alere Inc., Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Grifols S.A. 

This report segments the global hemostasis diagnostics market into:

Global Hemostasis Diagnostics Market: Product Type Analysis

  • Laboratory Systems
  • Consumables
  • Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market: Test Type Analysis

  • Prothrombin Test Time (PT)
  • Activated Partial Thromboplastin Time (APTT)
  • Fibrinogen Degradation Products (FDP)
  • Activated Clotting Time
  • Platelet Aggregation Test
  • D Dimer

Global Hemostasis Diagnostics Market: End-User Analysis

  • Hospital and Clinics
  • Independent Diagnostic Laboratories
  • Home Care Settings

Global Hemostasis Diagnostics Market: Regional Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 3
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Hemostasis Diagnostics Market, 2015 - 2024 (USD Billion)
    • 2.2. Global Hemostasis Diagnostics Market: Snapshot
  • Chapter 3. Hemostasis Diagnostics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Hemostasis Diagnostics Market drivers: Impact analysis
      • 3.2.2. Increased prevalence of Hemostasis diseases
      • 3.2.3. increase in healthcare facilities, increase in expenditure on advanced and developing healthcare facilities
    • 3.3. Market Restraints
      • 3.3.1. Stringent regulatory policies
      • 3.3.2. High cost of advanced hemostasis products
    • 3.4. Opportunities
      • 3.4.1. High spending on R&D
      • 3.4.2. Adoption of new technologies
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by Test Type
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  • Chapter 4. Global Hemostasis Diagnostics Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Hemostasis Diagnostics Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  • Chapter 5. Global Hemostasis Diagnostics Market - Product Type Analysis
    • 5.1. Global Hemostasis Diagnostics Market: Product Type overview
      • 5.1.1. Global Hemostasis Diagnostics Market revenue share, by Product Type, 2015 and 2024(USD Billion)
    • 5.2. Laboratory Systems
      • 5.2.1. Global Laboratory Systems market, 2015 - 2024 (USD Billion)
    • 5.3. Consumables
      • 5.3.1. Global Consumables market, 2015 - 2024 (USD Billion)
    • 5.4. Point-of-Care Testing Systems
      • 5.4.1. Global Point-of-Care Testing Systems market, 2015 - 2024(USD Billion)
  • Chapter 6. Global Hemostasis Diagnostics Market - Test Type Analysis
    • 6.1. Global Hemostasis Diagnostics Market: Test Type overview
      • 6.1.1. Global Hemostasis Diagnostics Market revenue share, by indication, 2015 and 2024(USD Billion)
    • 6.2. Prothrombin Test Time (PT)
      • 6.2.1. Global Prothrombin Test Time (PT) market, 2015 - 2024(USD Billion)
    • 6.3. Activated Partial Thromboplastin Time (APTT)
      • 6.3.1. Global Activated Partial Thromboplastin Time (APTT) market, 2015 - 2024(USD Billion)
    • 6.4. Fibrinogen Degradation Products (FDP)
      • 6.4.1. Global Fibrinogen Degradation Products (FDP) market, 2015 - 2024(USD Billion)
    • 6.5. Activated Clotting Time
      • 6.5.1. Global Activated Clotting Time market, 2015 - 2024(USD Billion)
    • 6.6. Platelet Aggregation Test
      • 6.6.1. Global Platelet Aggregation Test market, 2015 - 2024(USD Billion)
    • 6.7. D Dimer
      • 6.7.1. Global D Dimer market, 2015 - 2024(USD Billion)
  • Chapter 7. Global Hemostasis Diagnostics Market - End-User Analysis
    • 7.1. Global Hemostasis Diagnostics Market: End-User overview
      • 7.1.1. Global Hemostasis Diagnostics Market revenue share, by End-User, 2014 and 2024(USD Billion)
    • 7.2. Hospital & Clinics
      • 7.2.1. Global Hemostasis Diagnostics Market for Hospital & Clinics, 2015 - 2024(USD Billion)
    • 7.3. Independent Diagnostic Laboratories
      • 7.3.1. Global Hemostasis Diagnostics Market for Independent Diagnostic Laboratories, 2015 - 2024(USD Billion)
    • 7.4. Home Care Settings
      • 7.4.1. Global Hemostasis Diagnostics Market for Home Care Settings, 2015 - 2024(USD Billion)
  • Chapter 8. Global Hemostasis Diagnostics Market - Regional Analysis
    • 8.1. Global Hemostasis Diagnostics Market: Regional overview
      • 8.1.1. Global Hemostasis Diagnostics Market revenue share, by Region, 2015 and 2024
    • 8.2. North America
      • 8.2.1. North America Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.2.2. North America Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
      • 8.2.3. North America Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.2.4.2. The U.S. Hemostasis Diagnostics Market Revenue, by Test Type, 2015 - 2024(USD Billion)
        • 8.2.4.3. The U.S. Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.2.5.2. Rest of North America Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.2.5.3. Rest of North America Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.3.2. Europe Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
      • 8.3.3. Europe Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.3.4.2. Germany Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.3.4.3. Germany Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.3.5.2. UK Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.3.5.3. UK Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.3.6.2. France Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.3.6.3. France Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.3.7.2. Rest of Europe Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.3.7.3. Rest of Europe Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.4.2. Asia Pacific Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
      • 8.4.3. Asia Pacific Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.4.4.2. China Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.4.4.3. China Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.4.5.2. Japan Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.4.5.3. Japan Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.4.6.2. India Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.4.6.3. India Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.5.2. Latin America Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
      • 8.5.3. Latin America Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.5.4.2. Brazil Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.5.4.3. Brazil Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
        • 8.5.5.2. Rest of Latin America Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
        • 8.5.5.3. Rest of Latin America Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Hemostasis Diagnostics Market Revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.6.2. The Middle East and Africa Hemostasis Diagnostics Market Revenue, by Test Type , 2015 - 2024(USD Billion)
      • 8.6.3. The Middle East and Africa Hemostasis Diagnostics Market revenue, by End-User, 2015 - 2024(USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Abbott Laboratories
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Test Type portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Thermo Fisher Scientific Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Test Type portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Alere Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Test Type portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. F. Hoffmann-La Roche Ltd.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Test Type portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Nihon Kohden Corporation
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Test Type portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Sysmex Corporation
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Test Type portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Siemens Healthineers
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Test Type portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Instrumentation Laboratory
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Test Type portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Danaher Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Test Type portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Grifols S.A.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Test Type portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

Adroll
adroll